Clinical Trial Update: Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors [Phase 2]

View source ↗

Summary

This document notes a Phase 2 clinical trial evaluating the efficacy and safety of adding icaritin to the mFOLFOX chemotherapy regimen for patients with hepatoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Folinic acid (folinic acid)
• Icaritin (icaritin)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Northern Jiangsu People's Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: RECRUITING